Jill Becker
About Jill Becker
Jill Becker serves as the CLIA Lab Director at Octapharma Plasma, Inc. and holds multiple roles in cannabinoid medicine and expressive arts therapy, demonstrating a diverse background in medicine and psychology.
Work at Octapharma Plasma
Jill Becker serves as the CLIA Lab Director at Octapharma Plasma, Inc. since 2019. In this role, she oversees laboratory operations, ensuring compliance with Clinical Laboratory Improvement Amendments (CLIA) regulations. Her responsibilities include managing lab staff, maintaining quality control, and implementing best practices in laboratory procedures. The position is based in Brockton, Ontario, Canada, where she contributes to the organization’s mission of providing high-quality plasma products.
Current Roles at inhaleMD
At inhaleMD, Jill Becker holds dual roles as an Attending Physician and the Director of Cannabinoid Medicine Fellowship. She has been with the organization since 2020, focusing on patient care and education in cannabinoid medicine. As the Director of the fellowship program, she is responsible for developing curriculum and training future specialists in the field. Her work supports the integration of cannabinoid therapies into medical practice.
Education and Expertise
Jill Becker has an extensive educational background in medicine and psychology. She earned her Doctor of Medicine (M.D.) from the University of Massachusetts Medical School. Additionally, she holds a Master of Arts (M.A.) in Expressive Arts Therapy and Counseling Psychology from William James College. Her foundational studies include a Bachelor of Arts (B.A.) in Psychology from Brandeis University and training in Psychosynthesis from the Synthesis Center.
Leadership at Association of Cannabinoid Specialists
Jill Becker has been serving as the Vice President of Communication at the Association of Cannabinoid Specialists since 2021. In this leadership role, she is responsible for overseeing communication strategies and initiatives that promote the association's goals. Her involvement helps advance the understanding and application of cannabinoid therapies within the medical community.